GSK Aktie
| 21,56EUR | -0,23EUR | -1,06% |
WKN DE: A3DMB5 / ISIN: GB00BN7SWP63
Diese Analysten bewerten die GSK-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Deutsche Bank AG | 20,00£ | 8,05% | 18.09.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 0,22£ | -98,81% | 15.09.26 | |||
| JP Morgan Chase & Co. | 17,00£ | -8,16% | 14.09.26 | |||
| Jefferies & Company Inc. | 25,00£ | 35,06% | 14.09.26 | |||
| RBC Capital Markets | 19,75£ | 6,70% | 08.09.26 | |||
| Barclays Capital | 18,00£ | -2,76% | 08.09.26 | |||
| Bernstein Research | 30,10£ | 62,61% | 03.08.26 | |||
| Goldman Sachs Group Inc. | 18,90£ | 2,11% | 30.06.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|